Monday, September 15, 2025
HomeIndustriesHealthcare

Healthcare

Avidity Biosciences Announces Phase 1/2 EXPLORE44 Trial of AOC 1044 for Duchenne Muscular Dystrophy Mutations

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates announced the Phase 1/2 EXPLORE44™...

WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Toregem BioPharma, a biotech startup company from Kyoto University, announced that...

Ascend Continues Broad Expansion Into New Markets, Launches HiDura Med Portfolio

Ascend Performance Materials announced a new portfolio of medical grade nylon 6,6 resins and engineered materials for the healthcare market under its HiDura brand. HiDura...

Study Featured at NASS 2022 Demonstrates Long-Term Effectiveness of Centinel Spine’s Prodisc L Total Disc Replacement

Centinel Spine, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, announced findings of a new...

InsightRX Offers Precision Dosing Support for New Drug Categories

InsightRX, a precision dosing intelligence company, announced its expansion into three new therapeutic categories with the release of point-of-care dosing guidance for antifungal drugs,...
0FansLike
0FollowersFollow
spot_img

Hot Topics